Anti-inflammatory ω-3 endocannabinoid epoxides.
paper
Cited
Public
Unavailable
- Authors
- McDougle, Daniel R; Watson, Josephine E; Abdeen, Amr A; Adili, Reheman; Caputo, Megan P; Krapf, John E; Johnson, Rodney W; Kilian, Kristopher A; Holinstat, Michael; Das, Aditi
- Year
- 2017
- Journal
- Proceedings of the National Academy of Sciences of the United States of America
- PMID
- 28687674
- DOI
- 10.1073/pnas.1610325114
- PMCID
- PMC5544256
Clinical studies suggest that diets rich in ω-3 polyunsaturated fatty acids (PUFAs) provide beneficial anti-inflammatory effects, in part through their conversion to bioactive metabolites. Here we report on the endogenous production of a previously unknown class of ω-3 PUFA-derived lipid metabolites that originate from the crosstalk between endocannabinoid and cytochrome P450 (CYP) epoxygenase metabolic pathways. The ω-3 endocannabinoid epoxides are derived from docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) to form epoxyeicosatetraenoic acid-ethanolamide (EEQ-EA) and epoxydocosapentaenoic acid-ethanolamide (EDP-EA), respectively. Both EEQ-EAs and EDP-EAs are endogenously present in rat brain and peripheral organs as determined via targeted lipidomics methods. These metabolites were directly produced by direct epoxygenation of the ω-3 endocannabinoids, docosahexanoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA) by activated BV-2 microglial cells, and by human CYP2J2. Neuroinflammation studies revealed that the terminal epoxides 17,18-EEQ-EA and 19,20-EDP-EA dose-dependently abated proinflammatory IL-6 cytokines while increasing anti-inflammatory IL-10 cytokines, in part through cannabinoid receptor-2 activation. Furthermore the ω-3 endocannabinoid epoxides 17,18-EEQ-EA and 19,20-EDP-EA exerted antiangiogenic effects in human microvascular endothelial cells (HMVEC) and vasodilatory actions on bovine coronary arteries and reciprocally regulated platelet aggregation in washed human platelets. Taken together, the ω-3 endocannabinoid epoxides' physiological effects are mediated through both endocannabinoid and epoxyeicosanoid signaling pathways. In summary, the ω-3 endocannabinoid epoxides are found at concentrations comparable to those of other endocannabinoids and are expected to play critical roles during inflammation in vivo; thus their identification may aid in the development of therapeutics for neuroinflammatory and cerebrovascular diseases.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A large-scale genome-wide association study meta-analysis of cannabis use disorder. | 2020 | 33096046 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Altered Plasma Endocannabinoids and Oxylipins in Adolescents with Major Depressive Disorders: A Case-Control Study. | Chakravarty A et al. | — | 2026 | → |
| Formulation and in vitro evaluation of liposomal and self-microemulsifying drug delivery systems for oral delivery of cannabidiol. | Protopapa C et al. | — | 2026 | → |
| Polynitrogen-containing compounds as multi-target sEH/FAAH inhibitors: Structure-activity relationship and pharmacological studies. | Tsang A et al. | — | 2026 | → |
| Adipogenicity-induced human mesenchymal stem cells treated with hemp seed oil stimulate brown-like adipocytes and decrease adipokine levels through the activation of cannabinoid receptor 2 (CB2). | Almousa A et al. | — | 2025 | → |
| Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation. | Durairaj P et al. | — | 2025 | → |
| C-reactive protein modulates lipid mediators in a pro-inflammatory direction. | Kurano M et al. | — | 2025 | → |
| Immune Dysregulation in Depression and Anxiety: A Review of the Immune Response in Disease and Treatment. | Hole C et al. | — | 2025 | → |
| International Symposium on Ruminant Physiology: The involvement of the endocannabinoid system in metabolic and inflammatory responses in dairy cows during negative energy balance. | Zachut M et al. | — | 2025 | → |
| Molecular mechanisms of cytochrome P450-derived epoxy-fatty acids neuroprotection. | Navarro-Mabarak C et al. | — | 2025 | → |
| N-Acylethanolamines in cancer: mechanisms and therapeutic potential of lipid regulators of tumor behavior. | Nanì MF et al. | — | 2025 | → |
| Nutraceutical eicosapentaenoic acid in treatment-resistant depression: The psychoneuroimmunity and clinical implications. | Chang JP et al. | — | 2025 | → |
| Omega-3 fatty acid supplementation from late pregnancy to early lactation attenuates the endocannabinoid system and immune proteome in preovulatory follicles and endometrium of Holstein dairy cows. | Dos S Silva P et al. | — | 2025 | → |
| Omega-3 polyunsaturated fatty acids and mortality risk in depression: immune-inflammatory mediation in NHANES 1999-2018. | Ren XL et al. | — | 2025 | → |
| Persistent immune dysregulation and metabolic alterations following SARS-CoV-2 infection | Lucena Lage S et al. | — | 2025 | — |
| The Hunt for the Putative Epoxyeicosatrienoic Acid Receptor. | Arnold WR et al. | — | 2025 | → |
| Cardioprotective properties of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids. | Kranrod J et al. | — | 2024 | → |
| Cold-induced changes in plasma signaling lipids are associated with a healthier cardiometabolic profile independently of brown adipose tissue. | Jurado-Fasoli L et al. | — | 2024 | → |
| Comparative Study of Gas and Liquid Chromatography Methods for the Determination of Underivatised Neutral and Acidic Cannabinoids and Cholesterol. | Czauderna M et al. | — | 2024 | → |
| Differences in total and differential white blood cell counts and in inflammatory parameters between psychiatric inpatients with and without recent consumption of cannabinoids, opioids, or cocaine: A retrospective single-center study. | Llorca-Bofí V et al. | — | 2024 | → |
| Impact of nutrition on skin wound healing and aesthetic outcomes: A comprehensive narrative review. | Seth I et al. | — | 2024 | → |
| Real time changes in the expression of eicosanoid synthesizing enzymes during inflammation. | Huff HC et al. | — | 2024 | → |
| Regulation of soluble epoxide hydrolase in renal-associated diseases: insights from potential mechanisms to clinical researches. | Gao P et al. | — | 2024 | → |
| Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention. | Soldevila-Domenech N et al. | — | 2024 | → |
| Unveiling the "hidden quality" of the walnut pellicle: a precious source of bioactive lipids. | Abbattista R et al. | — | 2024 | → |
| Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10. | Richter FC et al. | — | 2023 | → |
| Alterations of pain pathways by experimental sleep disturbances in humans: central pain-inhibitory, cyclooxygenase, and endocannabinoid pathways. | Haack M et al. | — | 2023 | → |
| Altered mucosal and plasma polyunsaturated fatty acids, oxylipins, and endocannabinoids profiles in Crohn's disease. | Ben-Mustapha Y et al. | — | 2023 | → |
| Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. | Mock ED et al. | — | 2023 | → |
| Assay of Endocannabinoid Oxidation by Cytochrome P450. | Snider NT et al. | — | 2023 | → |
| Fatty acid binding proteins are novel modulators of synaptic epoxyeicosatrienoic acid signaling in the brain. | Glaser ST et al. | — | 2023 | → |
| Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles. | Kalkman HO | — | 2023 | → |
| Landscape of gut microbiota and metabolites and their interaction in comorbid heart failure and depressive symptoms: a random forest analysis study. | Huang K et al. | — | 2023 | → |
| Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway. | Frömel T et al. | — | 2023 | → |
| Measuring brain docosahexaenoic acid turnover as a marker of metabolic consumption. | Klievik BJ et al. | — | 2023 | → |
| Metabolic Reprogramming of Microglia in Sepsis-Associated Encephalopathy: Insights from Neuroinflammation. | Gao S et al. | — | 2023 | → |
| N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model. | Simard M et al. | — | 2023 | → |
| Nutritional lipidomics for the characterization of lipids in food. | Calderón C et al. | — | 2023 | → |
| Preparing Patients for Cosmetic Surgery and Aesthetic Procedures: Ensuring an Optimal Nutritional Status for Successful Results. | Vitagliano T et al. | — | 2023 | → |
| Role of omega-3 and omega-6 endocannabinoids in cardiopulmonary pharmacology. | Tang TY et al. | — | 2023 | → |
| Role of omega-3 endocannabinoids in the modulation of T-cell activity in a multiple sclerosis experimental autoimmune encephalomyelitis (EAE) model. | Kim JS et al. | — | 2023 | → |
| The Endocannabinoid System in Caenorhabditis elegans. | Estrada-Valencia R et al. | — | 2023 | → |
| The Role of Omega-3 Polyunsaturated Fatty Acids and Their Lipid Mediators on Skeletal Muscle Regeneration: A Narrative Review. | Jannas-Vela S et al. | — | 2023 | → |
| Anthracycline derivatives inhibit cardiac CYP2J2. | Kim JS et al. | — | 2022 | → |
| A practical strategy to develop isoform-selective near-infrared fluorescent probes for human cytochrome P450 enzymes. | Feng L et al. | — | 2022 | → |
| Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families. | Simard M et al. | — | 2022 | → |
| Current knowledge of the implication of lipid mediators in psoriasis. | Simard M et al. | — | 2022 | → |
| Detoxification Cytochrome P450s (CYPs) in Families 1-3 Produce Functional Oxylipins from Polyunsaturated Fatty Acids. | Eccles JA et al. | — | 2022 | → |
| Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease. | Torres-Mendoza BMG et al. | — | 2022 | → |
| Dietary Omega-3 Polyunsaturated Fatty-Acid Supplementation Upregulates Protective Cellular Pathways in Patients with Type 2 Diabetes Exhibiting Improvement in Painful Diabetic Neuropathy. | Durán AM et al. | — | 2022 | → |
| Endocannabinoid-Based Therapies. | Piomelli D et al. | — | 2022 | → |
| Fatty Acid-Derived <i>N</i>-acylethanolamines Dietary Supplementation Attenuates Neuroinflammation and Cognitive Impairment in LPS Murine Model. | Tyrtyshnaia A et al. | — | 2022 | → |
| Hemodialysis and biotransformation of erythrocyte epoxy fatty acids in peripheral tissue. | Liu T et al. | — | 2022 | → |
| Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed. | Ben Necib R et al. | — | 2022 | → |
| Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19. | Kocherlakota C et al. | — | 2022 | → |
| Molecular and Signaling Mechanisms for Docosahexaenoic Acid-Derived Neurodevelopment and Neuroprotection. | Kim HY et al. | — | 2022 | → |
| Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives. | Calapai F et al. | — | 2022 | → |
| Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system. | Zhou L et al. | — | 2022 | → |
| PUFA-Derived <i>N</i>-Acylethanolamide Probes Identify Peroxiredoxins and Small GTPases as Molecular Targets in LPS-Stimulated RAW264.7 Macrophages. | de Bus IA et al. | — | 2022 | → |
| Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs. | Zhang Y et al. | — | 2022 | → |
| Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease. | Nolan JM et al. | — | 2022 | → |
| Supplementation with dietary omega-3 PUFA mitigates fetal brain inflammation and mitochondrial damage caused by high doses of sodium nitrite in maternal rats. | Sun J et al. | — | 2022 | → |
| Therapeutic role of eicosapentaenoic and arachidonic acid in benzo(a) pyrene-induced toxicity in HUVEC endothelial cells. | Sroczyńska K et al. | — | 2022 | → |
| Adrenic Acid-Derived Epoxy Fatty Acids Are Naturally Occurring Lipids and Their Methyl Ester Prodrug Reduces Endoplasmic Reticulum Stress and Inflammatory Pain. | Singh N et al. | — | 2021 | → |
| Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances. | Sheng Y et al. | — | 2021 | → |
| Anti-Inflammatory Activity of <i>N</i>-Docosahexaenoylethanolamine and <i>N</i>-Eicosapentaenoylethanolamine in a Mouse Model of Lipopolysaccharide-Induced Neuroinflammation. | Tyrtyshnaia A et al. | — | 2021 | → |
| Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel. | Arnold WR et al. | — | 2021 | → |
| Comparing the In Vitro Antitumor, Antioxidant and Anti-Inflammatory Activities between Two New Very Long Chain Polyunsaturated Fatty Acids, Docosadienoic Acid (DDA) and Docosatrienoic Acid (DTA), and Docosahexaenoic Acid (DHA). | Chen Y et al. | — | 2021 | → |
| Cytochrome P450-epoxygenated fatty acids inhibit Müller glial inflammation. | Ontko CD et al. | — | 2021 | → |
| Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature. | Kalkman HO et al. | — | 2021 | → |
| Effects of a CB<sub>2</sub> Subtype Selective Agonist ABK5-1 on Cytokine Production in Microglia. | Tang Y et al. | — | 2021 | → |
| Effects of Dietary n-3 and n-6 Polyunsaturated Fatty Acids in Inflammation and Cancerogenesis. | Liput KP et al. | — | 2021 | → |
| Effects of Nutrients on Platelet Function: A Modifiable Link between Metabolic Syndrome and Neurodegeneration? | Arnoldussen IAC et al. | — | 2021 | → |
| Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders. | Sharma DS et al. | — | 2021 | → |
| Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects. | Alvarez-Mon MA et al. | — | 2021 | → |
| Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors. | Wilt S et al. | — | 2021 | → |
| Immunomodulating effects of 13- and 16-hydroxylated docosahexaenoyl ethanolamide in LPS stimulated RAW264.7 macrophages. | de Bus I et al. | — | 2021 | → |
| Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models. | Depommier C et al. | — | 2021 | → |
| Maternal omega-3 intake differentially affects the endocannabinoid system in the progeny`s neocortex and hippocampus: Impact on synaptic markers. | Isaac AR et al. | — | 2021 | → |
| Mediterranean Diet and Neurodegenerative Diseases: The Neglected Role of Nutrition in the Modulation of the Endocannabinoid System. | Armeli F et al. | — | 2021 | → |
| Modulation of Endocannabinoids by Caloric Restriction Is Conserved in Mice but Is Not Required for Protection from Acute Kidney Injury. | Hoyer-Allo KJR et al. | — | 2021 | → |
| Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation. | Kasatkina LA et al. | — | 2021 | → |
| Novel Strategies to Prevent Total Parenteral Nutrition-Induced Gut and Liver Inflammation, and Adverse Metabolic Outcomes. | Lucchinetti E et al. | — | 2021 | → |
| Omega-3 nutraceuticals, climate change and threats to the environment: The cases of Antarctic krill and Calanus finmarchicus. | Prado-Cabrero A et al. | — | 2021 | → |
| Quality of Life and a Surveillant Endocannabinoid System. | de Melo Reis RA et al. | — | 2021 | → |
| Sarcopenia: Etiology, Nutritional Approaches, and miRNAs. | Cannataro R et al. | — | 2021 | → |
| Systematic review of marine-derived omega-3 fatty acid supplementation effects on leptin, adiponectin, and the leptin-to-adiponectin ratio. | Rausch J et al. | — | 2021 | → |
| A large-scale genome-wide association study meta-analysis of cannabis use disorder. | Johnson EC et al. | — | 2020 | → |
| An Activity-Based Sensing Approach for the Detection of Cyclooxygenase-2 in Live Cells. | Yadav AK et al. | — | 2020 | → |
| Brain eicosapentaenoic acid metabolism as a lead for novel therapeutics in major depression. | Bazinet RP et al. | — | 2020 | → |
| CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design. | Das A et al. | — | 2020 | → |
| Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases. | Atone J et al. | — | 2020 | → |
| Effect of flaxseed oil supplementation on the erythrocyte membrane fatty acid composition and endocannabinoid system modulation in patients with coronary artery disease: a double-blind randomized controlled trial. | Saleh-Ghadimi S et al. | — | 2020 | → |
| Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology. | Tanaka M et al. | — | 2020 | → |
| Hemodialysis and erythrocyte epoxy fatty acids. | Gollasch B et al. | — | 2020 | → |
| Influence of the Technological Process on the Biochemical Composition of Fresh Roe and Bottarga from <i>Liza ramada</i> and <i>Mugil cephalus</i>. | Corrias F et al. | — | 2020 | → |
| <i>n</i>-3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer. | Giordano C et al. | — | 2020 | → |
| <i>N</i>-Docosahexanoylethanolamine Reduces Microglial Activation and Improves Hippocampal Plasticity in a Murine Model of Neuroinflammation. | Tyrtyshnaia A et al. | — | 2020 | → |
| Omega-3 Eicosapentaenoic Acid Is Related to Happiness and a Sense of Fulfillment-A Study among Female Nursing Workers. | Tsuboi H et al. | — | 2020 | → |
| Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1. | Power R et al. | — | 2020 | → |
| The Association Between Vascular Inflammation and Depressive Disorder. Causality, Biomarkers and Targeted Treatment. | Kalkman HO | — | 2020 | → |
| The Biosynthesis of Enzymatically Oxidized Lipids. | Hajeyah AA et al. | — | 2020 | → |
| A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression. | Diab J et al. | — | 2019 | → |
| Direct and indirect effects of lipids on microglia function. | Leyrolle Q et al. | — | 2019 | → |
| Emerging class of omega-3 fatty acid endocannabinoids & their derivatives. | Watson JE et al. | — | 2019 | → |
| Enhanced responsiveness of platelets to vicagrel in IL-10-deficient mice through STAT3-dependent up-regulation of the hydrolase arylacetamide deacetylase in the intestine. | Jia YM et al. | — | 2019 | → |
| Fatty acids and selected endocannabinoids content in cerebrospinal fluids from patients with neuroinfections. | Czepiel J et al. | — | 2019 | → |
| Fatty acid suppression of glial activation prevents central neuropathic pain after spinal cord injury. | Georgieva M et al. | — | 2019 | → |
| Herring roe oil supplementation alters microglial cell gene expression and reduces peripheral inflammation after immune activation in a neonatal piglet model. | Caputo MP et al. | — | 2019 | → |
| Metabolomics revealed decreased level of omega-3 PUFA-derived protective eicosanoids in pregnant women with pre-eclampsia. | Liu Y et al. | — | 2019 | → |
| Novel COX-2 products of <i>n</i>-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages. | de Bus I et al. | — | 2019 | → |
| Overview of the Components of Cardiac Metabolism. | Hausner EA et al. | — | 2019 | → |
| Possible prophylactic effect of omega-3 fatty acids on cadmium-induced neurotoxicity in rats' brains. | Alnahdi HS et al. | — | 2019 | → |
| Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation. | Kodani SD et al. | — | 2019 | → |
| The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? | Moreno E et al. | — | 2019 | → |
| The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation. | de Bus I et al. | — | 2019 | → |
| The Role of Nutrition for the Aging Population: Implications for Cognition and Alzheimer's Disease. | Power R et al. | — | 2019 | → |
| Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides. | Roy J et al. | — | 2018 | → |
| Are Long-Chain Polyunsaturated Fatty Acids the Link between the Immune System and the Microbiome towards Modulating Cancer? | Ilag LL | — | 2018 | → |
| Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3. | Mangoni AA et al. | — | 2018 | → |
| Combination of arginine, glutamine, and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST): A prospective, randomized, double-blind study. | Ma C et al. | — | 2018 | → |
| Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid. | Isobe Y et al. | — | 2018 | → |
| Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2. | Arnold WR et al. | — | 2018 | → |
| Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. | Kodani SD et al. | — | 2018 | → |
| Endocannabinoid Virodhamine Is an Endogenous Inhibitor of Human Cardiovascular CYP2J2 Epoxygenase. | Carnevale LN et al. | — | 2018 | → |
| N-Docosahexaenoylethanolamine: A neurotrophic and neuroprotective metabolite of docosahexaenoic acid. | Kim HY et al. | — | 2018 | → |
| Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics. | Imig JD | — | 2018 | → |
| Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids. | Adili R et al. | — | 2018 | → |
| Long-chain omega-3 fatty acids in aneurysmal subarachnoid hemorrhage: A randomized pilot trial of pharmaconutrition. | Saito G et al. | — | 2017 | → |
| Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases. | Chilton FH et al. | — | 2017 | → |
| Research progress of mechanisms and drug therapy for neuropathic pain. | Yan YY et al. | — | 2017 | → |
| The Imbalance between n-6/n-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Disease: A Comprehensive Review and Future Therapeutic Perspectives. | Scaioli E et al. | — | 2017 | → |